Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MarketBeat's profile

Blog
Stream if You Want to Go Faster: Netflix's New $120 Target
Stream if You Want to Go Faster: Netflix's New $120 Target

In a market often focused on uncertainty, a decisive signal on April 6, 2026, has captured the investment community's attention. Prominent financial institution Goldman Sachs (NYSE: GS) issued a

Is D-Wave the Latest Threat to Bitcoin?
Is D-Wave the Latest Threat to Bitcoin?

As Bitcoin has been trading sideways for two months and remains significantly below its 2025 all-time high, quantum computing firms like D-Wave Quantum Inc. (NYSE: QBTS) may be the latest force to

Rocket Lab Gets Approval to Acquire Mynaric: Why This Matters
Rocket Lab Gets Approval to Acquire Mynaric: Why This Matters

Rocket Lab (NASDAQ: RKLB) has taken a major step forward in its vertical integration strategy. The company announced that it has received regulatory approval to acquire Mynaric, a leading provider

The Bottom Is in for Micron Stock: 3 Signals to Buy Now
The Bottom Is in for Micron Stock: 3 Signals to Buy Now

Micron Technology’s (NASDAQ: MU) stock price has been volatile, and the wild swings are unlikely to be over.

However, a mix of technical signals, institutional positioning, and analyst expectations

A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?

In the world of investing, stability is a prized commodity. Few companies embody that stability better than Abbott Laboratories (NYSE: ABT), a diversified healthcare powerhouse and a member of the